Gene · 54541
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer. | Int J Mol Sci | 2022 | 35897761 | PubTator, text mining | PubMed |
| The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. | Int J Mol Sci | 2022 | 35897651 | PubTator, text mining | PubMed |
| Glyphosate infiltrates the brain and increases pro-inflammatory cytokine TNFα: implications for neurodegenerative disorders. | J Neuroinflammation | 2022 | 35897073 | PubTator, text mining | PubMed |
| Remarkable immune and clinical value of novel ferroptosis-related genes in glioma. | Sci Rep | 2022 | 35896732 | PubTator, text mining | PubMed |
| Antioxidant Systems, lncRNAs, and Tunneling Nanotubes in Cell Death Rescue from Cigarette Smoke Exposure. | Cells | 2022 | 35892574 | PubTator, text mining | PubMed |
| Role of p53 in Regulating Radiation Responses. | Life (Basel) | 2022 | 35888186 | PubTator, text mining | PubMed |
| Medical Aspects of mTOR Inhibition in Kidney Transplantation. | Int J Mol Sci | 2022 | 35887051 | PubTator, text mining | PubMed |
| Identification of Antitumor miR-30e-5p Controlled Genes; Diagnostic and Prognostic Biomarkers for Head and Neck Squamous Cell Carcinoma. | Genes (Basel) | 2022 | 35886008 | PubTator, text mining | PubMed |
| mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases. | Antioxidants (Basel) | 2022 | 35883796 | PubTator, text mining | PubMed |
| Altered genome-wide hippocampal gene expression profiles following early life lead exposure and their potential for reversal by environmental enrichment. | Sci Rep | 2022 | 35879375 | PubTator, text mining | PubMed |
| Induction of Ferroptosis by Ophiopogonin-B Through Regulating the Gene Signature AURKA in NSCLC. | Front Oncol | 2022 | 35875069 | PubTator, text mining | PubMed |
| PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib. | Sci Rep | 2022 | 35864202 | PubTator, text mining | PubMed |
| Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions. | Cancer Res | 2022 | 35857801 | PubTator, text mining | PubMed |
| Establishment and Analysis of a Combined Diagnostic Model of Alzheimer's Disease With Random Forest and Artificial Neural Network. | Front Aging Neurosci | 2022 | 35847663 | PubTator, text mining | PubMed |
| Modulation of mTOR Signaling in Cardiovascular Disease to Target Acute and Chronic Inflammation. | Front Cardiovasc Med | 2022 | 35845058 | PubTator, text mining | PubMed |
| Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the MALAT1/miR-383-5p/DDIT4 signaling pathway. | J Gastrointest Oncol | 2022 | 35837196 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Will Sirtuin 2 Be a Promising Target for Neuroinflammatory Disorders? | Front Cell Neurosci | 2022 | 35813508 | PubTator, text mining | PubMed |
| Genome-wide Meta-analysis Reveals New Gene Signatures and Potential Drug Targets of Hypertension. | ACS Omega | 2022 | 35811894 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54541/papers?page=39